USC researchers share discoveries on Alzheimer’s disease and discuss strategies to fight the illness
A newly approved yet controversial drug, in particular, brings both hope and challenges for patients and clinicians.
Newly revealed potential treatment target for Alzheimer’s could help with late-stage disease
A new USC study may have unlocked therapy options to slow cognitive impairment in people with the APOE4 gene, which has long been associated with Alzheimer’s disease.
Keck School of Medicine awarded $2 million to help identify if financial vulnerability is risk factor for Alzheimer’s
A grant from the National Institutes of Health will allow the Han Research Lab to study the link between financial decision-making and Alzheimer’s disease.
Five Surprising Ways Plants Can Keep You Healthy
You might find a hangover cure, protection against Alzheimer’s and much more in nature’s bounty.
Brain changes following traumatic brain injury share similarities with Alzheimer’s disease
Using MRIs and machine learning, USC researchers mapped comparable degenerative changes in both gray and white matter of the brain.
Potential Alzheimer’s disease treatments could lead to significant state Medicaid savings
New disease-modifying treatments would help Medicaid avoid paying $186 billion from 2021 to 2040, a new USC study has found.
Does air pollution increase women’s risk of dementia?
High levels of fine particle pollution are associated with brain shrinkage patterns common in Alzheimer’s disease, a USC study finds.
USC leads new artificial intelligence study of Alzheimer’s disease
A $17.8 million grant from the National Institutes of Health will fund an AI-powered study of genetic, imaging and cognitive data collected from Alzheimer’s patients.
New clinical trial will test deep brain stimulation as Alzheimer’s treatment
Keck Medicine of USC is now enrolling individuals in a phase 3 clinical trial that will implant electrodes into subjects’ brains to potentially stop the progression of the disease.
Restricted blood flow in the brain could be tied to Alzheimer’s
A USC research team has found strong evidence that keeping blood vessels healthy can help prevent cognitive decline.
Training and diversifying the next generation of Alzheimer’s researchers
The inaugural class of the IMPACT-AD program, which is co-directed by a USC professor, will educate 35 professionals at various career stages on conducting more diverse clinical trials.
New research center to address social and economic impacts of Alzheimer’s
USC’s Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease will explore the enormous costs of Alzheimer’s and related dementias.
Dementia-related deaths in the U.S. may be higher than reported
Death certificate data appear to underestimate the true mortality burden of dementia, Alzheimer’s disease and other cognitive impairment, according to a USC-led study.
Targeting these 12 risk factors could prevent or delay almost half of dementia cases
“It’s never too early or too late to take action,” says Lon Schneider of the Keck School of Medicine of USC, co-director of the USC Alzheimer Disease Research Center’s clinical core.
New Alzheimer’s treatments won’t be widely accessible without changes to national health systems
USC research shows how several major countries could prepare their health systems to ensure patients can get Alzheimer’s treatments once they hit the market.
Alzheimer’s gene triggers early breakdowns in blood-brain barrier, predicting cognitive decline
Although scientists have long known APOE4 is a leading risk factor for Alzheimer’s disease, they were unsure how exactly it drives a decline in memory. USC researchers now believe they have an answer.
Certain combinations of cardiovascular drugs may reduce dementia risk
In a first, a USC study has shown that drugs already being used for blood pressure and cholesterol control could provide benefits for Alzheimer’s and other dementias.
Alzheimer’s study aims to see if drug can block brain plaques linked to disease
Keck School of Medicine of USC is launching a large clinical trial that targets amyloid plaques in the brain. The goal: to see whether a drug can clear or slow this plaque in people who have early Alzheimer’s or who appear clinically normal.
As an Alzheimer’s crisis looms, the director of USC’s aging institute focuses on prevention
María Aranda will bring her expertise as a researcher and a social worker to Gov. Gavin Newsom’s Task Force on Alzheimer’s Prevention and Preparedness.
NIH funding for USC Alzheimer’s research grew by more than 400% in 4 years
Funding from the National Institutes of Health — the world’s largest public funder of biomedical research — was $68 million last year, a substantial increase from $13 million in 2015.
Averting Alzheimer’s through exercise, clean air and an active social calendar
November is Alzheimer’s Awareness Month, and USC scientists are researching healthy lifestyle choices and certain drugs that might reduce the risk of developing the disease.
USC study connects air pollution, memory problems and Alzheimer’s-like brain changes
Women in their 70s and 80s who were exposed to fine particle pollution had declines in memory and physical brain changes that were not seen in women who breathed cleaner air.
Facebook Live: The state of Alzheimer’s research
Christian Pike of the USC Leonard Davis School of Gerontology and USC health policy expert Julie Zissimopoulos as they discuss the latest research into the disease.
Alzheimer’s disease impacts women in higher numbers and different ways
As Alzheimer’s Awareness Month begins, USC researchers examine how the disease affects men and women, including theories on estrogen depletion and higher life expectancy.